Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice

British Journal of Pharmacology

Volumn 141, Issue 4, 2004, Pages 755-763

  Piovezan, Anna P ^a   D'Orléans Juste, Pedro ^b   Frighetto, Monica ^a   Souza, Glória E P ^c   Henriques, Maria G M O ^d   Rae, Giles A ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Allergy; Antigen; Endothelin; Inflammation; Nociception; Ovalbumin; Pain

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ALUMINUM HYDROXIDE; ATRASENTAN; BOSENTAN; COMPOUND 48-80; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN DERIVATIVE; MORPHINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OVALBUMIN; SARAFOTOXIN S6C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HYPERALGESIA; IMMEDIATE TYPE HYPERSENSITIVITY; INHIBITION KINETICS; MALE; MAST CELL; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REACTION ANALYSIS; SENSITIZATION;

ANIMALS; ANTIGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; HYPERALGESIA; HYPERSENSITIVITY; INDICATORS AND REAGENTS; MALE; MICE; OLIGOPEPTIDES; OVALBUMIN; P-METHOXY-N-METHYLPHENETHYLAMINE; PAIN; PEPTIDES, CYCLIC; PIPERIDINES; SULFONAMIDES; VIPER VENOMS;

EID: 11144358010     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705663     Document Type: Article

References (58)

1. BENOIST, C. & MATHIS, D. (2002). Mast cells in autoimmune disease. Nature, 420, 875-887.
2. CATERINA, M.J., SCHUMACHER, M.A., TOMINAGA, M., ROSEN, T.A., LEVINE, J.D. & JULIUS, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816-824.
3. CHURCH, M.K., OKAYAMA, Y. & EL-LATI, S. (1991). Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation. Skin Pharmacol., 4, 15-24.
4. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LOFFLER, B.M., BURRI, K., CASSAL, J.M., HIRTH, G., MULLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
5. DAHLOF, B., GUSTAFSSON, D., HEDNER, T., JERN, S. & HANSSON, L. (1990). Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J. Hypertens., 8, 811-817.
6. DAVAR, G., HANS, G., FAREED, M.U., SINNOTT, C. & STRICHARTZ, G. (1998). Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport, 9, 2279-2283.
7. DE-MELO, J.D., TONUSSI, C.R., D'ORLÉANS-JUSTE, P. & RAE, G.A. (1998). Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists. Pain, 77, 261-269.
8. DUPERRAY, A., MANTOVANI, A., INTRONA, M. & DEJANA, E. (1995). Endothelial cell regulation of leucocyte infiltration in inflammatory tissues. Mediat. Inflamm., 4, 322-330.
9. DUPUIS, J., JASMIN, J.F., PRIE, S. & CERNACECK, P. (2000). Importance of local production of endothelin-1 and of the ET(B)-receptor in the regulation of pulmonary vascular tone. Pulm. Pharmacol. Ther., 13, 135-140.
10. EHRENREICH, H., ANDERSON, R.W., FOX, C.H., RIECKMANN, P., HOFFMAN, G.S., TRAVIS, W.D., COLIGAN, J.E., KEHRL, J.H. & FAUCI, A.S. (1990). Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J. Exp. Med., 172, 1741-1748.
11. FERREIRA, S.H., ROMITELLI, M. & DE NUCCI, G. (1989). Endothelin-1 participation in overt and inflammatory pain. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), S220-S222.
12. FILEP, J.G., TELEMAQUE, S., BATTISTINI, B., SIROIS, P. & D'ORLÉANS-JUSTE, P. (1993). Increased plasma levels of endothelin during anaphylactic shock in the guinea-pig. Eur. J. Pharmacol., 239, 231-236.
13. GILBERT, R.E., RUMBLE, J.R., CAO, Z., COX, A.J., VAN EEDEN, P., ALLEN, T.J., KELLY, D.J. & COOPER, M.E. (2000). Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ. Res., 86, 158-165.
14. GOMEZ-GARRE, D., GUERRA, M., GONZALEZ, E., LOPEZ-FARRE, A., RIESCO, A., CARAMELO, C., ESCANERO, J. & EGIDO, J. (1992). Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor. Eur. J. Pharmacol., 224, 167-172.
15. GORDON, S. (2002). Pattern recognition receptors: doubling up for the innate immune response. Cell, 111, 927-930.
16. GRAVEN-NIELSEN, T., JANSSON, Y., SEGERDAHL, M., KRISTENSEN, J.D., MENSE, S., ARENDT-NIELSEN, L. & SOLLEVI, A. (2003). Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline. Eur. J. Pain, 7, 93-102.
17. GRISWOLD, D.E., DOUGLAS, S.A., MARTIN, L.D., DAVIS, T.G., DAVIS, L., AO, Z., LUTTMANN, M.A., PULLEN, M., NAMBI, P., HAY, D.W. & OHLSTEIN, E.H. (1999). Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol. Pharmacol., 56, 807-812.
18. GUIMARÃES, C.L., TRENTIN, P.G. & RAE, G.A. (2002). Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice. Clin. Sci., 103 (Suppl. 48), 340S-344S.
19. HONORÉ, J.C., PLANTE, M., BKAILY, G., RAE, G.A. & D'ORLÉANS-JUSTE, P. (2002). Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs. Br. J. Pharmacol., 136, 819-828.
20. JAFFERY, G., COLEMAN, J.W., HUNTLEY, J. & BELL, E.B. (1994). Mast cell recovery following chronic treatment with compound 48/80. Int. Arch. Allergy Immunol., 105, 274-280.
21. JARVIS, M.F., WESSALE, J.L., ZHU, C.Z., LYNCH, J.J., DAYTON, B.D., CALZADILLA, S.V., PADLEY, R.J., OPGENORTH, T.J. & KOWALUK, E.A. (2000). ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur. J. Pharmacol., 388, 29-35.
22. KEDZIERSKI, R.M. & YANAGISAWA, M. (2001). Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol., 41, 851-876.
23. KHODOROVA, A., FAREED, M.U., GOKIN, A., STRICHARTZ, G.R. & DAVAR, G. (2002). Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner. J. Neurosci., 22, 7788-7796.
24. KHODOROVA, A., NAVARRO, B., JOUAVILLE, L.S., MURPHY, J.E., RICE, F.L., MAZURKIEWICZ, J.E., LONG-WOODWARD, D., STOFFEL, M., STRICHARTZ, G.R., YUKHANANOV, R. & DAVAR, G. (2003). Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med., 9, 1055-1061.
25. KIZAWA, Y., KOTAKE, H., KUSAMA, T., SAlTO, K. & MURAKAMI, H. (1999). Antigen-induced elevation of immunoreactive endothelin-1 (ET-1) levels in ovalbumin-sensitized guinea pig airway tissue. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol., 122, 239-243.
26. KODA, W., HARADA, K., TSUNEYAMA, K., KONO, N., SASAKI, M., MATSUI, O. & NAKANUMA, Y. (2000). Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree. Lab. Invest., 80, 1007-1017.
27. KUROSE, I., MIURA, S., FUKUMURA, D. & TSUCHIYA, M. (1993). Mechanisms of endothelin-induced macromolecular leakage in microvascular beds of rat mesentery. Eur. J. Pharmacol., 250, 85-94.
28. LAVICH, T.R., CORDEIRO, R.S., CALIXTO, J.B., SILVA, P.M. & MARTINS, M.A. (2003). Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. Eur. J. Pharmacol., 462, 185-192.
29. LI, Z., NIWA, Y., ROKUTAN, K. & NAKAYA, Y. (1999). Expression of endothelin-1 in macrophages and mast cells in hyperplastic human tonsils. FEBS Lett., 457, 381-384.
30. LIU, Y., YAMADA, H. & OCHI, J. (1998). Immunocytochemical studies on endothelin in mast cells and macrophages in the rat gastrointestinal tract. Histochem. Cell Biol., 109, 301-307.
31. MASAKI, T., VANE, J.R. & VANHOUTTE, P.M. (1994). International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev., 46, 137-142.
32. MENÉNDEZ, L., LASTRA, A., HIDALGO, A. & BAAMONDE, A. (2003). Nociceptive reaction and thermal hyperalgesia induced by local ET-1 in mice: a behavioral and Fos study. Naunyn Schmiedbergs Arch. Pharmacol., 367, 28-34.
33. MOUSLI, M., BUEB, J.L., BRONNER, C., ROUOT, B. & LANDRY, Y. (1990). G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci., 11, 358-362.
34. NAKANO, A., KISHI, F., MINAMI, K., WAKABAYASHI, H., NAKAYA, Y. & KIDO, H. (1997). Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acid-length endothelins by chymase from human mast cells. J. Immunol., 159, 1987-1992.
35. A-selective receptor antagonist. J. Pharmacol. Exp. Ther., 276, 473-481.
36. PALUCKA, K. & BANCHEREAU, J. (2002). How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol., 14, 420-431.
37. PARADA, C.A., TAMBELLI, C.H., CUNHA, F.Q. & FERREIRA, S.H. (2001). The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience, 102, 937-944.
38. B receptor activation. Br. J. Pharmacol., 129, 961-968.
39. PIOVEZAN, A.P., D'ORLÉANS-JUSTE, P., TONUSSI, C.R. & RAE, G.A. (1997). Endothelins potentiate formalin-induced nociception and paw edema in mice. Can. J. Physiol. Pharmacol., 75, 596-600.
40. PIOVEZAN, A.P., D'ORLÉANS-JUSTE, P., TONUSSI, C.R. & RAE, G.A. (1998). Effects of endothelin-1 on capsaicin-induced nociception in mice. Eur. J. Pharmacol., 351, 15-22.
41. B receptors. J. Pharmacol. Exp. Ther., 276, 647-651.
42. RIBEIRO, R.A., VALE, M.L., THOMAZZI, S.M., PASCHOALATO, A.B.P., POOLE, S., FERREIRA, S.H. & CUNHA, F.Q. (2000). Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur. J. Pharmacol., 387, 111-118.
43. RUGGIERI, M.R., FILER-MAERTEN, S., HIEBLE, J.P. & HAY, D.W. (2000). Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder. J. Urol., 164, 197-202.
44. A receptor antagonists inhibit allergic inflammation in the mouse. J. Cardiovasc. Pharmacol., 26 (Suppl. 3), S416-S418.
45. SAMPAIO, A.L., RAE, G.A. & HENRIQUES, M.G. (2000). Participation of endogenous endothelins in delayed eosinophil and neutrophil recruitment in mouse pleurisy. Inflamm. Res., 49, 170-176.
46. SHIGEMATSU, T., MIURA, S., HIROKAWA, M., HOKARI, R., HIGUCHI, H., WATANABE, N., TSUZUKI, Y., KIMURA, H., TADA, S., NAKATSUMI, R.C., SAITO, H. & ISHII, H. (1998). Induction of endothelin-1 synthesis by IL-2 and its modulation of rat intestinal epithelial cell growth. Am. J. Physiol., 275, G556-G563.
47. 2. Eur. J. Pharmacol., 214, 119-125.
48. SOFIA, M., MORMILE, M., FARAONE, S., ALIFANO, M., ZOFRA, S., ROMANO, L. & CARRATU, L. (1993). Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration, 60, 89-95.
49. TOMINAGA, K., ALSTERGREN, P., KURITA, H. & KOPP, S. (1999). Clinical course of an antigen-induced arthritis model in the rabbit temporomandibular joint. J. Oral Pathol. Med., 28, 268-273.
50. TRAKADA, G., TSOURAPIS, S., MARANGOS, M. & SPIROPOULOS, K. (2000). Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir. Med., 94, 992-996.
51. UCHIDA, Y., NINOMIYA, H., SAKAMOTO, T., LEE, J.Y., ENDO, T., NOMURA, A., HASEGAWA, S. & HIRATA, F. (1992). ET-1 released histamine from guinea pig pulmonary but not peritoneal mast cells. Biochem. Biophys. Res Commun., 189, 1196-1201.
52. B selectivity. J. Med. Chem., 42, 3668-3678.
53. WACNIK, P.W., EIKMEIER, L.J., RUGGLES, T.R., RAMNARAINE, M.L., WALCHECK, B.K., BEITZ, A.J. & WILCOX, G.L. (2001). Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J. Neurosci., 21, 9355-9366.
54. WATANABE, T., ARAKAWA, T., TOMINAGA, K., FUJIWARA, Y., HIGUCHI, K. & KUROKI, T. (2000). Neutrophil accumulation in development gastric ulcer induced by submucosal injection of endothelin-1 in rats. Dig. Dis. Sci., 45, 880-888.
55. WATKINS, L.R. & MAIER, S.F. (2002). Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev., 82, 981-1011.
56. WEDEMEYER, J., TSAI, M. & GALLI, S.J. (2000). Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immun., 12, 624-631.
57. YAMAMURA, H., NABE, T., KOHNO, S. & OHATA, K. (1994). Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur. J. Pharmacol., 265, 9-15.
58. ZIMMERMANN, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.